Blue Origin successfully launched a NASA Mars mission on the second flight of its New Glenn booster Nov. 13, landing the ...

Cassava Sciences, Inc. (NASDAQ: SAVA, "Cassava", the "Company"), a biotechnology company focused on developing novel, investigational treatments for central nervous system (CNS) disorders such as ...

Infrastructure adjusted EBITDA in the third quarter of 2025 -- $23.5 million, up $2.6 million from the prior year period, ...

Researchers have developed a powerful new software toolbox that allows realistic brain models to be trained directly on data.

US stocks fell sharply on Thursday, led by a decline in tech stocks as the end of the longest-ever US government shutdown was ...

New! Sign up for our free email newsletter.

Alzheimer's disease (AD), the leading cause of dementia, affects nearly 40 million individuals globally, resulting in a gradual loss of memory and independence. Despite extensive research over the ...